Evidence map›Paper›PMID 41721984›Full record

ArticleEuropean journal of epidemiology2026

Projections of the global, regional and national stroke burden by 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Minghong Yao, Mingqi Wang, Yu Ma, Jason W Busse, Xin Hu, Yanmei Liu, Xiaochao Luo, Qigao Liang, Xiao Liang, Kang Zou and 2 more

Abstract read
In one paragraph

Article in European journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Minghong Yao *Department of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Mingqi Wang *Department of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Yu MaDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Jason W BusseMichael G DeGroote National Pain Centre, McMaster University, Hamilton, ON, L8S 4K1, Canada.
Xin HuDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
Yanmei LiuDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Xiaochao LuoDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Qigao LiangDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Xiao LiangDepartment of Encephalopathy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Kang ZouDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
Ling LiDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China. liling@wchscu.cn.
Xin SunDepartment of Neurosurgery and Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, West China Hospital, Sichuan University, Chengdu, China. sunxin@wchscu.cn.ORCID http://orcid.org/0000-0002-6554-7088

Funding

1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University ZYGD23004a Canadian Institutes of Health Research Canada Research Chair in Prevention & Management of Chronic Pain a Canadian Institutes of Health Research Canada Research Chair in Prevention & Management of Chronic PainInnovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine ZYYCXTD-D-202402National Natural Science Foundation of China 82274368National Science Fund for Distinguished Young Scholars 82225049
6 · The paper itself

Abstract

This study projected the incidence, prevalence, death and disability-adjusted life-years (DALYs) attributable to total strokes and pathological types in people aged ≥ 15 years for 204 countries and territories to 2050. Age- and sex-specific trends in rates were developed using XGBoost models incorporating national human development index, gross domestic product per capita, and demographic data from the Global Burden of Disease study, the World Bank, and the United Nations. Uncertainty intervals were calculated as the 2.5th and 97.5th percentiles of the distribution using a bootstrap-like method. From 2021 to 2050, the global absolute number of incident strokes is anticipated to increase by 31.64% (27.78–35.61), prevalent strokes by 58.00% (54.68–60.62), deaths from stroke by 11.88% (5.83–19.28), and DALYs due to stroke by 17.86% (10.63–25.18). Meanwhile, the age-standardised rate of stroke prevalence will increase by 2.67% (1.47–4.23). However, the age-standardised rates of stroke incidence, death and DALYs are projected to decrease by 8.54% (6.87–10.07), 21.51% (19.18–23.92) and 18.44% (15.83–20.95), respectively. In 2050, males are projected to exceed females across all age-standardised metrics. Ischaemic stroke will account for the largest proportion of the total-stroke burden, the burden of stroke in low to middle SDI countries will account for more than half of the total global burden of stroke, and Southeast Asia, East Asia, and Oceania are projected to have the highest stroke burden in absolute numbers. Our projections suggested the global burden of stroke will increase substantially from 2021 to 2050, despite reductions in age-standardised rates.

Indexed as

Global Burden of DiseaseGlobal HealthStrokeAdolescentAdultAgedAge DistributionDisability-Adjusted Life YearsFemaleForecastingHumansIncidenceMaleMiddle AgedPrevalenceQuality-Adjusted Life YearsDeathsDisability-adjusted life yearsGlobal burden of diseaseIncidencePrevalenceStroke

Identifiers

PMID41721984
PMCPMC13222217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.